» Articles » PMID: 15901778

Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex

Overview
Journal J Neurosci
Specialty Neurology
Date 2005 May 20
PMID 15901778
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Recent linkage studies have identified a significant association of the neuregulin gene with schizophrenia, but how neuregulin is involved in schizophrenia is primarily unknown. Aberrant NMDA receptor functions have been implicated in the pathophysiology of schizophrenia. Therefore, we hypothesize that neuregulin, which is present in glutamatergic synaptic vesicles, may affect NMDA receptor functions via actions on its ErbB receptors enriched in postsynaptic densities, hence participating in emotional regulation and cognitive processes that are impaired in schizophrenia. To test this, we examined the regulation of NMDA receptor currents by neuregulin signaling pathways in prefrontal cortex (PFC), a prominent area affected in schizophrenia. We found that bath perfusion of neuregulin significantly reduced whole-cell NMDA receptor currents in acutely isolated and cultured PFC pyramidal neurons and decreased NMDA receptor-mediated EPSCs in PFC slices. The effect of neuregulin was mainly blocked by application of the ErbB receptor tyrosine kinase inhibitor, phospholipase C (PLC) inhibitor, IP3 receptor (IP3R) antagonist, or Ca2+ chelators. The neuregulin regulation of NMDA receptor currents was also markedly attenuated in cultured neurons transfected with mutant forms of Ras or a dominant-negative form of MEK1 (mitogen-activated protein kinase kinase 1). Moreover, the neuregulin effect was prevented by agents that stabilize or disrupt actin polymerization but not by agents that interfere with microtubule assembly. Furthermore, neuregulin treatment increased the abundance of internalized NMDA receptors in cultured PFC neurons, which was also sensitive to agents affecting actin cytoskeleton. Together, our study suggests that both PLC/IP3R/Ca2+ and Ras/MEK/ERK (extracellular signal-regulated kinase) signaling pathways are involved in the neuregulin-induced reduction of NMDA receptor currents, which is likely through enhancing NR1 internalization via an actin-dependent mechanism.

Citing Articles

Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways.

Zhang T, Liu C, Zhong N, Wang Y, Huang Y, Zhang X Int J Mol Sci. 2024; 25(19).

PMID: 39408997 PMC: 11477438. DOI: 10.3390/ijms251910668.


Cortical links glutamatergic signaling to NREM sleep EEG slow waves in an activity-dependent manner.

Kompotis K, Mang G, Hubbard J, Jimenez S, Emmenegger Y, Polysopoulos C Proc Natl Acad Sci U S A. 2024; 121(3):e2220532121.

PMID: 38207077 PMC: 10801902. DOI: 10.1073/pnas.2220532121.


Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats.

Nawwar D, Zaki H, Sayed R Inflammopharmacology. 2022; 30(5):1891-1907.

PMID: 35876932 PMC: 9499910. DOI: 10.1007/s10787-022-01031-w.


Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study.

Vrillon A, Mouton-Liger F, Martinet M, Cognat E, Hourregue C, Dumurgier J Alzheimers Res Ther. 2022; 14(1):71.

PMID: 35606871 PMC: 9125890. DOI: 10.1186/s13195-022-01014-7.


Actin and Diseases of the Nervous System.

Bernstein B, Maloney M, Bamburg J Adv Neurobiol. 2022; 5:201-234.

PMID: 35547659 PMC: 9088176. DOI: 10.1007/978-1-4419-7368-9_11.


References
1.
Jentsch J, Roth R . The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1999; 20(3):201-25. DOI: 10.1016/S0893-133X(98)00060-8. View

2.
Leonard A, Lim I, Hemsworth D, Horne M, Hell J . Calcium/calmodulin-dependent protein kinase II is associated with the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 1999; 96(6):3239-44. PMC: 15926. DOI: 10.1073/pnas.96.6.3239. View

3.
WESTPHAL R, Tavalin S, Lin J, Alto N, Fraser I, Langeberg L . Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science. 1999; 285(5424):93-6. DOI: 10.1126/science.285.5424.93. View

4.
Fu A, Cheung W, Ip F, Ip N . Identification of genes induced by neuregulin in cultured myotubes. Mol Cell Neurosci. 1999; 14(3):241-53. DOI: 10.1006/mcne.1999.0784. View

5.
Rieff H, Raetzman L, Sapp D, Yeh H, Siegel R, Corfas G . Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J Neurosci. 1999; 19(24):10757-66. PMC: 6784934. View